Natalia Navas

7PUBLICATIONS
7CO-AUTHORS
Nanotoxicology, health and safetyCellular immunologyMedical molecular engineering of nucleic acids and proteinsGlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 23, 2026
Pharmaceutical Stability of Romiplostim: In-use Functional Study Using Microscale Thermophoresis New Strategy and Elisa.

|Sep 28, 2024
Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding.

Alicia Torres-García, Anabel Torrente-López, Jesús Hermosilla

|Nov 25, 2023
Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate.

Jesús Hermosilla, Airan Alonso-García, Antonio Salmerón-García

|Oct 20, 2022
Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS.

Raquel Pérez-Robles, Antonio Salmerón-García, Susana Clemente-Bautista

|Apr 23, 2022
Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress.

Anabel Torrente-López, Jesús Hermosilla, Antonio Salmerón-García

|Jun 02, 2021
The Relevance of Monoclonal Antibodies in the Treatment of COVID-19.

Anabel Torrente-López, Jesús Hermosilla, Natalia Navas

Pageof 2

Frequent Collaborators

4 joint publications

José Cabeza-Barrera

2 joint publications

Anabel Torrente-López

2 joint publications

Jesús Hermosilla

1 joint publications

Luis Cuadros-Rodríguez